DATE OF BIRTH: September 20, 1973CITIZENSHIP: AustrianLANGUAGES: Fluent in English, German, French, Spanish, and FarsiMARITAL STATUS: SingleC U R R E N T P O S I T I O N SProfessor and ChairmanDepartment of UrologyMedical University of <strong>Vienna</strong><strong>Vienna</strong> General HospitalWähringer Gürtel 18-20A-1090 <strong>Vienna</strong>, AustriaTel: +43 1 40400 2615Cell: +43 664 8001651010Fax: +43 1 40400 2332Email: sfshariat@gmail.com or shahrokh.shariat@meduniwien.ac.atAdjunct Professor of Urology and Medical OncologyWeill Cornell Medical CollegeNew York, NY, USAAdjunct Professor of UrologyUniversity of Texas Southwestern Medical CenterDallas, TX, USA4/2013-present4/2013-present5/2013-presentwww.vienna-omi.at 28.08.2013
E D U C A T I O N & M E D I C A L T R A I N I N GUNIVERSITY OF VIENNA MEDICAL SCHOOL, <strong>Vienna</strong>, Austria 1993 – 1998Doctor of MedicineThesis: “Impact of dialysis on serum total PSA, free PSA and free to total PSA ratio:is prostate cancer detection compromised in patients on chronic hemodialysis?”UNIVERSITY OF LA LAGUNA MEDICAL SCHOOL, La Laguna, Spain 1995 – 1996SWISS FEDERAL INSTITUTE OF TECHNOLOGY, Lausanne, Switzerland 1992 – 1993Pre-diploma in mathematics, physics, chemistry with distinctionLYCEE FRANÇAIS DE VIENNE, <strong>Vienna</strong>, Austria 1979 – 1992French Baccalaureate and Austrian MaturaA C A D E M I C T R A C KMEDICAL UNIVERSITY OF VIENNA, <strong>Vienna</strong>, AustriaProfessor and Chairman of Urology4/2013 - presentWEILL CORNELL MEDICAL COLLEGE /NEW YORK-PRESBYTERIAN HOSPITAL, New York, NYAdjunct Professor of Urology and Associate Professor of Medical Oncology 4/2013 – presentAssistant Professor of Urology and Associate Professor of Medical Oncology 2010 – 2012Associate Professor of Urology and Associate Professor of Medical Oncology 2012 – 2013Director, Bladder Cancer Outcomes and Translational Research 2011 –2013Director, Urologic Oncology Fellowship Program 2012 –2013MEMORIAL SLOAN-KETTERING CANCER CENTER, New York, NY 6/2008 – 7/2010Fellow/Faculty Instructor, Urologic OncologyUNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER, Dallas, TXAdjunct Professor of Urology2013 – presentChief Resident in Urology 2007– 2008Resident in Urology 2004– 2007Intern in Surgery 2003– 2004Faculty Instructor, Urologic Oncology 2002– 2003BAYLOR COLLEGE OF MEDICINE, Houston, TXFaculty Instructor, Urologic Oncology 2001– 2002Postdoctoral Fellowship, Urologic Oncology 1999–2000Postdoctoral Frost Fellowship in Gene Therapy for Urologic Diseases 1998–1999P R O F E S S I O N A L M E M B E R S H I P Swww.vienna-omi.at 28.08.2013
- Page 1: SHAHROKH F. SHARIAT, MDProfessor an
- Page 5 and 6: • Glaxo SmithKline Scholar Award,
- Page 7 and 8: May 29-June 3, 2010. J.Urol 183(4):
- Page 9 and 10: • Leading Physician of the World
- Page 11 and 12: Weill Cornell Medical Center, Princ
- Page 13 and 14: Inventor: Shahrokh ShariatThe prese
- Page 15 and 16: • Chair of Sessions - The Inaugur
- Page 17 and 18: • Guest Editor of special issue o
- Page 19 and 20: • Visiting Professor, Division of
- Page 21 and 22: Ablative therapy for small renal co
- Page 23 and 24: Bladder cancer: opportunities for i
- Page 25 and 26: 7. Merseburger AS, Herrmann TR, Sha
- Page 27 and 28: 36. May M, Ficarra V, Shariat SF, Z
- Page 29 and 30: Results from of a Large Multicenter
- Page 31 and 32: trends and disparities in the use o
- Page 33 and 34: 112. Abdollah F, Sun M, Thuret R, J
- Page 35 and 36: 139. Fajkovic H, Cha EK, Jeldres C,
- Page 37 and 38: RK, Margulis V, Shariat SF: Tissue-
- Page 39 and 40: 21869907190. Abdollah F, Sun M, Jel
- Page 41 and 42: Montorsi F, Karakiewicz PI: The imp
- Page 43 and 44: Fradet Y, Shariat SF. Prognostic ri
- Page 45 and 46: 271. Shariat SF, Lotan Y, Vickers A
- Page 47 and 48: 298. Shariat SF, Kattan MW, Vickers
- Page 49 and 50: 324. Capitanio U, Isbarn H, Shariat
- Page 51 and 52: 349. Margulis V, Shariat SF, Matin
- Page 53 and 54:
378. Karakiewicz PI, Bhojani N, Cap
- Page 55 and 56:
410. Shariat SF, Lamb DJ, Iyengar R
- Page 57 and 58:
442. Chun FK, Briganti A, Gallina A
- Page 59 and 60:
cystectomy for primary nontransitio
- Page 61 and 62:
Slawin KM. Salvage radiotherapy for
- Page 63 and 64:
535. Shariat SF, Desai S, Song W, K
- Page 65 and 66:
21. SunM., Abdollah F., Schmitges J
- Page 67 and 68:
progression after radical prostatec
- Page 69 and 70:
Y., Karakiewicz P.: Assessement of
- Page 71 and 72:
50. Shariat S., Karakiewicz P., Fra
- Page 73 and 74:
predictions in patients with adreno
- Page 75 and 76:
Schoenberg, G. E. Amiel, S. P. Lern
- Page 77 and 78:
113. Claudio Jeldres, Maxime Crepel
- Page 79 and 80:
(volume 183 issue 4 Page e227)134.
- Page 81 and 82:
156. Ramy Youssef, Shahrokh Shariat
- Page 83 and 84:
Localized .Sunday, May 15, 2011 Ame
- Page 85 and 86:
Health Conference. 2-5 October 2011
- Page 87 and 88:
urothelial carcinoma. Poster #155.
- Page 89 and 90:
supplementation on the prevention o
- Page 91 and 92:
for metastatic renal cell carcinoma
- Page 93 and 94:
muscle-invasive urothelial carcinom
- Page 95 and 96:
Shahrokh Shariat Prediction of intr
- Page 97 and 98:
Terrone; Derya Tilki; Daniel Vergho
- Page 99 and 100:
P.I.: Drs. Shahrokh Shariat and Dou